[Big blind spot syndrome (papillophlebitis) with unusual visual field defect]. 2013

Anikó Rózsa, and Krisztina Kovács, and Krisztina Boór, and Agnes Vagyóczky, and Ildikó Szilvássy, and Gyula Gács
Péterfy Sándor Utcai Kórház, Neurológiai és Szemészeti Osztály, Budapest. rossanny@freemail.hu

We present three cases, where young patients had unilateral disc edema with normal optic nerve function. We diagnosed their disease as big blind spot syndrome (BBSS). What is remarkable, however, is that in two of the three cases the extent of the visual field defect considerably exceeded the one regularly emerging in BBSS, which caused us some difficulty in differential diagnosis. The characteristics and the differential diagnostic questions of the big blind spot syndrome are summarised and we would like to draw attention to this unusual, but probably not very rare, form of it.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009898 Optic Disk The portion of the optic nerve seen in the fundus with the ophthalmoscope. It is formed by the meeting of all the retinal ganglion cell axons as they enter the optic nerve. Blind Spot,Optic Disc,Optic Nerve Head,Optic Papilla,Blind Spots,Disc, Optic,Disk, Optic,Head, Optic Nerve,Nerve Head, Optic,Optic Discs,Optic Disks,Optic Nerve Heads,Optic Papillas,Papilla, Optic,Papillas, Optic,Spot, Blind
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001623 Betamethasone A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724) Betadexamethasone,Flubenisolone,Celeston,Celestona,Celestone,Cellestoderm

Related Publications

Anikó Rózsa, and Krisztina Kovács, and Krisztina Boór, and Agnes Vagyóczky, and Ildikó Szilvássy, and Gyula Gács
April 2019, Klinische Monatsblatter fur Augenheilkunde,
Anikó Rózsa, and Krisztina Kovács, and Krisztina Boór, and Agnes Vagyóczky, and Ildikó Szilvássy, and Gyula Gács
September 1989, Journal of clinical neuro-ophthalmology,
Anikó Rózsa, and Krisztina Kovács, and Krisztina Boór, and Agnes Vagyóczky, and Ildikó Szilvássy, and Gyula Gács
January 2000, Survey of ophthalmology,
Anikó Rózsa, and Krisztina Kovács, and Krisztina Boór, and Agnes Vagyóczky, and Ildikó Szilvássy, and Gyula Gács
January 2020, QJM : monthly journal of the Association of Physicians,
Anikó Rózsa, and Krisztina Kovács, and Krisztina Boór, and Agnes Vagyóczky, and Ildikó Szilvássy, and Gyula Gács
January 1988, Archives of ophthalmology (Chicago, Ill. : 1960),
Anikó Rózsa, and Krisztina Kovács, and Krisztina Boór, and Agnes Vagyóczky, and Ildikó Szilvássy, and Gyula Gács
September 1984, Journal of clinical neuro-ophthalmology,
Anikó Rózsa, and Krisztina Kovács, and Krisztina Boór, and Agnes Vagyóczky, and Ildikó Szilvássy, and Gyula Gács
November 1952, Nordisk medicin,
Anikó Rózsa, and Krisztina Kovács, and Krisztina Boór, and Agnes Vagyóczky, and Ildikó Szilvássy, and Gyula Gács
September 1987, Journal of clinical neuro-ophthalmology,
Anikó Rózsa, and Krisztina Kovács, and Krisztina Boór, and Agnes Vagyóczky, and Ildikó Szilvássy, and Gyula Gács
July 1976, Journal of the American Optometric Association,
Anikó Rózsa, and Krisztina Kovács, and Krisztina Boór, and Agnes Vagyóczky, and Ildikó Szilvássy, and Gyula Gács
January 1997, Eye (London, England),
Copied contents to your clipboard!